Received Jan 3, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | YE232 | IM / RA |
The patient received a second RSV dose on 1/2/26, when previously they had received a dose on 8/11/24. According to CDC guidelines, patient should only receive one dose.
N/A
N/A
allopurinol 300mg, famotidine 20mg, meloxicam 15mg, olmesartan 20mg, triamcinolone 0.1 ointment, cetirizine 10mg, clobetasol 0.05% solution
N/A
N/A